Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HERAX | 9.82 | 0.09 | +0.92% |
| Hartford Emerging Markets Equity A | |||
| VSCIX | 99.26 | 0.84 | +0.85% |
| Vanguard Small Cap Index I | |||
| PDIFX | 13.71 | 0.10 | +0.73% |
| Principal Diversified International R6 | |||
| MCEFX | 13.61 | 0.06 | +0.44% |
| BlackRock International Select Eq Inv C | |||
| SGGDX | 36.44 | -0.46 | -1.25% |
| First Eagle Gold A | |||
A.I.dvisor tells us that SYGGF and INAB have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SYGGF and INAB's prices will move in lockstep.
| Ticker / NAME | Correlation To SYGGF | 1D Price Change % | ||
|---|---|---|---|---|
| SYGGF | 100% | +16.14% | ||
| INAB - SYGGF | 27% Poorly correlated | +2.09% | ||
| ATNF - SYGGF | 20% Poorly correlated | +2.43% | ||
| AWKNF - SYGGF | 15% Poorly correlated | N/A | ||
| CNTX - SYGGF | 3% Poorly correlated | -2.54% | ||
| CING - SYGGF | 2% Poorly correlated | +1.44% | ||
More | ||||